Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
PaperCitations, authors & open-access status
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 356 citations, 2021 year and green oa status.
356
Citations
2021
Year
green
OA Status